ALX Oncology Announces September Investor Conference Participation - ALX Oncology Holdings (NASDAQ:ALXO)
SOUTH SAN FRANCISCO, Calif., Aug. 31, 2023 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology") (NASDAQ:ALXO), a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint
Source: benzinga.com